Short Interest in Aterian, Inc. (NASDAQ:ATER) Grows By 57.7%

Aterian, Inc. (NASDAQ:ATERGet Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 264,469 shares, a growth of 57.7% from the March 15th total of 167,750 shares. Approximately 3.0% of the company’s stock are sold short. Based on an average daily trading volume, of 38,547 shares, the days-to-cover ratio is presently 6.9 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aterian in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce”.

Read Our Latest Stock Report on ATER

Institutional Trading of Aterian

Several institutional investors have recently modified their holdings of ATER. Citadel Advisors LLC raised its position in Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after purchasing an additional 22,865 shares during the last quarter. Susquehanna International Group LLP raised its position in Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Aterian by 73.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Aterian in the 2nd quarter valued at $55,000. Hedge funds and other institutional investors own 7.02% of the company’s stock.

Aterian Trading Up 0.9%

Shares of NASDAQ:ATER opened at $0.68 on Tuesday. The company has a market capitalization of $7.36 million, a PE ratio of -0.28 and a beta of 0.04. Aterian has a twelve month low of $0.52 and a twelve month high of $2.19. The firm has a 50 day simple moving average of $0.61 and a 200-day simple moving average of $0.76.

Aterian Company Profile

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Featured Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.